Lexicon Pharmaceuticals LXRX
NASDAQ LXRX
$1.82 -0.05 (-2.93%)
At close: Oct 1, 2026 · 4:00 PM EDT

Lexicon Pharmaceuticals (LXRX) Return on Equity [ROE] (2011 - 2026)

Updated

Lexicon Pharmaceuticals (LXRX) recorded Return on Equity [ROE] of -28.88% in Q2 2026, up 64.89 percentage points from -93.77% a year earlier but down 13.27 percentage points from the prior quarter.

Analysis

Lexicon Pharmaceuticals (LXRX) Return on Equity [ROE] (2011 - 2026) Analysis & Trends

For FY2025, Lexicon Pharmaceuticals reported Return on Equity [ROE] of -38.59%, up 126.32 percentage points from FY2024.

  • Annual Return on Equity [ROE] has a five-year change of +4.25 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Equity [ROE] came in at -164.91% in FY2024 (-1.52 pp), -163.39% in FY2023 (-73.64 pp), -89.75% in FY2022 (-24.74 pp) and -65.01% in FY2021 (-22.18 pp).
  • Quarterly Return on Equity [ROE] has ranged from -154.27% in Q4 2023 to -15.61% in Q1 2026 over the past five years.
  • On a year-over-year basis, Return on Equity [ROE] has increased for four consecutive quarters, with an average year-over-year change of +36.29 percentage points over the last eight quarters.
  • Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 225.51 percentage points in Q3 2021, against a drop of 144.79 percentage points in Q2 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at -15.61% (Q1 2026), -42.96% (Q4 2025) and -53.58% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.32%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 7.21%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 84.40%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 21.39%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 83.75%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -18.38%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.97%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 22.24%
10 Lexicon Pharmaceuticals 840.12 Mn 266.67 Mn 653,000.00 -28.88%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -28.88%
Mar 31, 2026 -15.61%
Dec 31, 2025 -42.96%
Sep 30, 2025 -53.58%
Jun 30, 2025 -93.77%
Mar 31, 2025 -131.95%
Dec 31, 2024 -121.50%
Sep 30, 2024 -100.89%
Jun 30, 2024 -76.00%
Mar 31, 2024 -100.42%
Dec 31, 2023 -154.27%
Sep 30, 2023 -100.70%
Jun 30, 2023 -98.03%
Mar 31, 2023 -110.17%
Dec 31, 2022 -79.30%
Sep 30, 2022 -91.03%
Jun 30, 2022 -118.58%
Mar 31, 2022 -87.62%
Dec 31, 2021 -70.26%
Sep 30, 2021 -49.49%
API Access

Lexicon Pharmaceuticals Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=LXRX&period=max&api_key=YOUR_API_KEY